Blue Pearl Agri (514440)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹46.44 |
| Market Cap | ₹1.2 Cr |
| P/E Ratio | 1,000 |
| ROCE | 2.57% |
| ROE | 2% |
| Dividend Yield | 0% |
| Profit Growth | -24.32% |
| Debt/Equity | — |
| Sales Growth | 32.75% |
| 52-Week Range | ₹18.98 — ₹105.04 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹0.43 |
Strengths
- Revenue growth of 32.75% shows the business is not shrinking.
- Positive annual ROE and ROCE, though thin, show some capital efficiency above zero.
- Tiny market cap of ₹1 Cr offers the possibility of outsized returns if a genuine operational turnaround occurs.
Concerns
- Extreme valuation: P/E of 1,000 and P/B of 108 are far ahead of underlying earnings and assets.
- Weak and deteriorating profitability: ROE 2%, ROCE 2.57%, profit growth -24.32%, and latest quarter net profit of ₹0 Cr.
- Piotroski F-score of 4/9 indicates poor financial health.
- No dividend yield and missing promoter holding/debt data create serious transparency and governance concerns.
AI Analysis
At ₹46.44, this is a company with a market capitalisation of just ₹1 crore—a microcap so small that it would barely move the needle in any serious portfolio. Graham taught me to pay for assets and earnings, and here I get neither. The book value is ₹0.43 per share, yet the price is 108 times book. Earnings support a P/E of 1,000, while return on equity is only 2% and ROCE is 2.57%. That is not a business; it is a scrap of equity being priced for perfection. Top line grew 32.75%, but bottom line fell 24.32%, and the latest quarter shows sales of ₹14 Cr with net profit of ₹0 Cr. Profit growth and sales growth must eventually align; here they are diverging. The Piotroski F-score of 4 out of 9 says the financial health is poor. With no dividend yield and a PEG ratio of 30.53, whatever growth exists is already more than paid for. Debt/equity and promoter holding are not available—unacceptable in a stock this size. In a commodity chemical business, where products are undifferentiated, there is no moat. Prices are dictated by the market, not by the company. The 52-week range of ₹18.98 to ₹114.61 tells me this is a speculative vehicle, not an investment. Unless there is a genuine, verifiable turnaround in margins and cash flow, the rational move is to stay away. I would need a large margin of safety, clear debt numbers, and evidence that the promoter is invested. None of that exists today. This is not a business to own; it is a ticket to trade. My rule: if I cannot calculate a conservative value with confidence, I move on.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer